Longitudinal and Cross-sectional Analysis of Pulmonary Microbiota in Lung Transplant Recipients Infected With Nocardia

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

September 1, 2024

Conditions
Nocardia InfectionsLung Transplantation
Interventions
DRUG

Antibiotic Treatment

"For lung transplant recipients with Nocardia infection, the treatment regimen could include:~Sulfamethoxazole/Trimethoprim (Bactrim): 800 mg/160 mg orally or intravenously twice daily for at least 6 months.~Imipenem: 500 mg intravenously every 6 hours for severe cases. Monitoring: Regular monitoring of blood levels of the drug to avoid toxicity and adjust doses accordingly."

Trial Locations (1)

510120

Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Zhibin Xu

OTHER